These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1908917)

  • 21. Electrophysiologic properties of flecainide acetate.
    Estes NA; Garan H; Ruskin JN
    Am J Cardiol; 1984 Feb; 53(5):26B-29B. PubMed ID: 6695816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular effects of optical isomers of cibenzoline, assessed in the canine isolated, blood-perfused papillary muscle and sinoatrial node preparations.
    Takehana S; Sugiyama A; Hashimoto K
    J Cardiovasc Pharmacol; 1999 Nov; 34(5):660-5. PubMed ID: 10547081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of negative inotropic effects of class Ic antiarrhythmic agents: comparative study of the effects of flecainide and pilsicainide on intracellular calcium handling in dog ventricular myocardium.
    Kihara Y; Inoko M; Hatakeyama N; Momose Y; Sasayama S
    J Cardiovasc Pharmacol; 1996 Jan; 27(1):42-51. PubMed ID: 8656657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ventricular and atrial electrophysiological effects of a IC antiarrhythmic drug, cibenzoline, in the innervated dog heart. Role of sodium and calcium channels.
    Timour Q; Aupetit JF; Loufoua-Moundanga J; Bertrix L; Freysz M; Faucon G
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Sep; 340(3):338-44. PubMed ID: 2554155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Profile of cardiovascular effects of NKH477, a novel forskolin derivative, assessed in isolated, blood-perfused dog heart preparations: comparison with isoproterenol.
    Ishizuka O; Hosono M; Nakamura K
    J Cardiovasc Pharmacol; 1992 Aug; 20(2):261-7. PubMed ID: 1381017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac effects of amiloride in the dog.
    Yamashita S; Motomura S; Taira N
    J Cardiovasc Pharmacol; 1981; 3(4):704-15. PubMed ID: 6167801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological profile of a new coronary vasodilator drug, 2-nicotinamidoethyl nitrate (SG-75).
    Taira N; Satoh K; Yanagisawa T; Imai Y; Hiwatari M
    Clin Exp Pharmacol Physiol; 1979; 6(3):301-16. PubMed ID: 157241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electrophysiological effects of penticainide in the anaesthetized dog.
    Sassine A; Brugada J; Munoz A; Romero-Ayala L; Masse C
    Drugs Exp Clin Res; 1987; 13(1):15-20. PubMed ID: 3595440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative study of coronary vasodilator and cardiac effects of nitrendipine by use of isolated, blood-perfused dog heart preparations.
    Satoh K; Wada Y; Taira N
    Arzneimittelforschung; 1986; 36(1):35-9. PubMed ID: 2937413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular profile of Bay K 8644, a presumed calcium channel activator, in the dog.
    Wada Y; Satoh K; Taira N
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Feb; 328(4):382-7. PubMed ID: 2581147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reconsideration of vascular selectivity of dihydropyridine calcium antagonists: comparison of cardiovascular profile of mepirodipine, a novel dihydropyridine consisting of a single stereoisomer with (+)-(S)-(S) conformation, with those of nifedipine and nicardipine.
    Motomura S; Hashimoto K
    Jpn J Pharmacol; 1990 Feb; 52(2):319-30. PubMed ID: 2313939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of flecainide on atrial and ventricular refractoriness in rabbits in vitro and in vivo.
    Leung MW; Chan AP; So PP; Lowe GC; Guppy LJ; Walker MJ
    Proc West Pharmacol Soc; 2004; 47():42-5. PubMed ID: 15633609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selectivity of alinidine, a bradycardic agent, for SA nodal automaticity versus other cardiac activities in isolated, blood-perfused dog-heart preparations.
    Kawada M; Satoh K; Taira N
    Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):88-102. PubMed ID: 6517649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac effects of the novel pyridazinone derivative 6-[4-[2-[3-(5-chloro-2-cyanophenoxy)-2-hydroxypropylamino]- 2- methylpropylamino]phenyl]-4,5-dihydro-5-methyl-3(2H) pyridazinone monoethyl maleate and its metabolite in isolated heart preparations of guinea pigs and dogs.
    Ishimori T; Gotanda K; Sasaki T; Shinbo A; Asano H; Miyazawa K; Miyasaka K
    Arzneimittelforschung; 1994 May; 44(5):583-8. PubMed ID: 7912931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms underlying the cardiovascular action of a new dihydropyridine vasodilator YC-93.
    Satoh K; Yanagisawa T; Taira N
    Clin Exp Pharmacol Physiol; 1980; 7(3):249-62. PubMed ID: 7406961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of flecainide on the rate dependence of atrial refractoriness, atrial repolarization and atrioventricular node conduction in anesthetized dogs.
    O'Hara G; Villemaire C; Talajic M; Nattel S
    J Am Coll Cardiol; 1992 May; 19(6):1335-42. PubMed ID: 1564235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular effects of methylflavonolamine hydrochloride (SIPI-549) in cross-circulated canine atrial and ventricular preparations.
    Chiba S; Akabane K; Furukawa Y; Karasawa Y
    Jpn Heart J; 1989 Jul; 30(4):511-21. PubMed ID: 2572710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different effects of flecainide on atrioventricular conduction properties in the adult and immature rabbit heart.
    Han HS; Hewett KW; McKay CA; Gillette PC; Case CL
    Cardiovasc Drugs Ther; 1997 Dec; 11(6):767-76. PubMed ID: 9512872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of dopamine on sinus rate and ventricular contractile force of the dog heart in vitro and in vivo.
    Endoh M
    Br J Pharmacol; 1975 Dec; 55(4):475-86. PubMed ID: 1212559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are the cardiovascular effects of gentamicin similar to those of calcium antagonists?
    Gotanda K; Yanagisawa T; Satoh K; Taira N
    Jpn J Pharmacol; 1988 Jul; 47(3):217-27. PubMed ID: 3221528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.